Folgen
George J Weiner
George J Weiner
Director Emeritus, Holden Comprehensive Cancer Center, C.E. Block Chair of Cancer Research
Bestätigte E-Mail-Adresse bei uiowa.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells
G Hartmann, GJ Weiner, AM Krieg
Proceedings of the National Academy of Sciences 96 (16), 9305-9310, 1999
8951999
Rituximab: mechanism of action
GJ Weiner
Seminars in hematology 47 (2), 115-123, 2010
8752010
Building better monoclonal antibody-based therapeutics
GJ Weiner
Nature Reviews Cancer 15 (6), 361-370, 2015
7732015
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
GJ Weiner, HM Liu, JE Wooldridge, CE Dahle, AM Krieg
Proceedings of the National Academy of Sciences 94 (20), 10833-10837, 1997
7221997
Cancer immunotherapy comes of age
SL Topalian, GJ Weiner, DM Pardoll
Journal of Clinical Oncology 29 (36), 4828, 2011
6082011
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
AM Krieg, G Weiner
US Patent 6,218,371, 2001
4442001
Cancer and inflammation: promise for biologic therapy
S Demaria, E Pikarsky, M Karin, LM Coussens, YC Chen, EM El-Omar, ...
Journal of immunotherapy 33 (4), 335-351, 2010
4092010
Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
KD Heckman, GJ Weiner, CS Davis, RG Strauss, MP Jones, CP Burns
Journal of clinical oncology 15 (3), 1143-1149, 1997
3691997
Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge
A Makkouk, GJ Weiner
Cancer research 75 (1), 5-10, 2015
3502015
Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs
ZK Ballas, AM Krieg, T Warren, W Rasmussen, HL Davis, M Waldschmidt, ...
The Journal of Immunology 167 (9), 4878-4886, 2001
3452001
Methods for enhancing antibody-induced cell lysis and treating cancer
G Weiner, G Hartmann
US Patent 7,534,772, 2009
2992009
Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma
JE Wooldridge, Z Ballas, AM Krieg, GJ Weiner
Blood, The Journal of the American Society of Hematology 89 (8), 2994-2998, 1997
2891997
Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab
JA Bowles, SY Wang, BK Link, B Allan, G Beuerlein, MA Campbell, ...
Blood 108 (8), 2648-2654, 2006
2762006
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
MT Drake, MJ Maurer, BK Link, TM Habermann, SM Ansell, IN Micallef, ...
Journal of clinical oncology 28 (27), 4191, 2010
2702010
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
SI Berndt, CF Skibola, V Joseph, NJ Camp, A Nieters, Z Wang, W Cozen, ...
Nature genetics 45 (8), 868-876, 2013
2412013
NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement
SY Wang, E Racila, RP Taylor, GJ Weiner
Blood, The Journal of the American Society of Hematology 111 (3), 1456-1463, 2008
2382008
Bispecific antibodies in cancer therapy
DM Segal, GJ Weiner, LM Weiner
Current opinion in immunology 11 (5), 558-562, 1999
2261999
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
MJ Maurer, E Bachy, H Ghesquières, SM Ansell, GS Nowakowski, ...
American journal of hematology 91 (11), 1096-1101, 2016
2172016
Uses of granulocyte-macrophage colony-stimulating factor in vaccine development
TL Warren, GJ Weiner
Current opinion in hematology 7 (3), 168-173, 2000
2092000
Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion
B Jahrsdörfer, A Vollmer, SE Blackwell, J Maier, K Sontheimer, T Beyer, ...
Blood, The Journal of the American Society of Hematology 115 (6), 1156-1165, 2010
1992010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20